Hypoxia, oxidative stress, and inflammation: three faces of neurodegenerative diseases

A Merelli, M Repetto, A Lazarowski… - Journal of Alzheimer's …, 2021 - content.iospress.com
The cerebral hypoxia-ischemia can induce a wide spectrum of biologic responses that
include depolarization, excitotoxicity, oxidative stress, inflammation, and apoptosis, and …

New insights into drug discovery targeting tau protein

Y Soeda, A Takashima - Frontiers in molecular neuroscience, 2020 - frontiersin.org
Microtubule-associated protein tau is characterized by the fact that it is an intrinsically
disordered protein due to its lack of a stable conformation and high flexibility. Intracellular …

Human tau-overexpressing mice recapitulate brainstem involvement and neuropsychiatric features of early Alzheimer's disease

KM Khan, N Balasubramanian, G Gaudencio… - Acta neuropathologica …, 2023 - Springer
Alzheimer's disease (AD) poses an ever-increasing public health concern as the population
ages, affecting more than 6 million Americans. AD patients present with mood and sleep …

Current pharmacophore based approaches for the development of new anti-Alzheimer's agents

P Sharma, S Sharma, Y Yadav, P Shukla… - Bioorganic & Medicinal …, 2024 - Elsevier
Amyloid beta peptide (Aβ) and hyperphosphorylated neuronal tau proteins accumulate in
neurofibrillary tangles in Alzheimer's disease (AD), a chronic neurodegenerative illness …

An inhibitor with GSK3β and DYRK1A dual inhibitory properties reduces Tau hyperphosphorylation and ameliorates disease in models of Alzheimer's disease

X Liu, L Lai, J Chen, X Li, N Wang, L Zhou, X Jiang… - …, 2023 - Elsevier
Since Alzheimer's disease (AD) is a complex and multifactorial neuropathology, the
discovery of multi-targeted inhibitors has gradually demonstrated greater therapeutic …

Fyn nanoclustering requires switching to an open conformation and is enhanced by FTLD-Tau biomolecular condensates

R Martínez-Mármol, C Small, A Jiang… - Molecular …, 2023 - nature.com
Fyn is a Src kinase that controls critical signalling cascades and has been implicated in
learning and memory. Postsynaptic enrichment of Fyn underpins synaptotoxicity in …

Fyn-tau ablation modifies PTZ-induced seizures and post-seizure hallmarks of early epileptogenesis

M Putra, S Puttachary, G Liu, G Lee… - Frontiers in cellular …, 2020 - frontiersin.org
Both Fyn and tau have been associated with neuronal hyperexcitability and neurotoxicity in
many tauopathies, including Alzheimer's disease (AD). Individual genetic ablation of fyn or …

Peptide aptamer targeting Aβ–PrP–Fyn axis reduces Alzheimer's disease pathologies in 5XFAD transgenic mouse model

T Ali, AN Klein, A Vu, MI Arifin, S Hannaoui… - Cellular and Molecular …, 2023 - Springer
Currently, no effective therapeutics exist for the treatment of incurable neurodegenerative
diseases such as Alzheimer's disease (AD). The cellular prion protein (PrPC) acts as a high …

Enhanced Fyn-tau and NR2B-PSD95 interactions in epileptic foci in experimental models and human epilepsy

M Putra, NS Rao, C Gardner, G Liu… - Brain …, 2024 - academic.oup.com
Epilepsy and Alzheimer's disease share some common pathologies such as
neurodegeneration, seizures and impaired cognition. However, the molecular mechanisms …

Isoform‐specific upregulation of FynT kinase expression is associated with tauopathy and glial activation in Alzheimer's disease and Lewy body dementias

CYB Low, JH Lee, FTW Lim, C Lee, C Ballard… - Brain …, 2021 - Wiley Online Library
Cumulative data suggest the involvement of Fyn tyrosine kinase in Alzheimer's disease
(AD). Previously, our group has shown increased immunoreactivities of the FynT isoform in …